Long-term patterns in kidney health indicators may predict heart failure risk

They say that an ounce of prevention is worth a pound of cure; knowing which preventive treatment to administer to which patient could undoubtedly up that yield.

SOR-007 by Nanology for Metastatic Adenocarcinoma of The Pancreas: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

December 22, 2023

Clinical Challenges: Helping Patients Navigate Safety Concerns of OTC Eye Drops

Artificial tears are the mainstay of dry eye disease (DED) management, and patients typically start by using over-the-counter (OTC) drops several times a day. But

November 28, 2023

ArriVent partners with Alphamab to develop ADCs for cancer

The partnership will utilise the technologies of Alphamab to detect promising ADC candidates for oncology indications. Credit: Nemes Laszlo/Shutterstock. ArriVent BioPharma has entered a partnership

June 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.